Target intelligence / Profile preview

Membrane-associated ring-CH-type finger protein 10 (MARCHF10)

Target
MARCHF10
Molecular classification
Enzyme, E3 ubiquitin ligase, RING-type E3 ubiquitin ligase, Membrane-associated protein
01

Overview

Membrane-associated ring-CH-type finger protein 10 (MARCHF10) is a member of the MARCH family of membrane-bound E3 ubiquitin ligases. These enzymes catalyze the transfer of ubiquitin to lysine residues of substrate proteins, often targeting them for proteasomal degradation or affecting their membrane localization and stability. MARCHF10 is predicted to contain a RING-CH domain (a variant of the canonical RING finger domain) and likely binds zinc ions as part of its structural motif. MARCH family proteins, including MARCHF10, act as critical regulators of immune responses by targeting immune receptors, viral proteins, and other membrane proteins for ubiquitination, thereby modulating their expression or activity at the cell surface. This regulation is relevant to processes such as immune surveillance, inflammation, and cellular homeostasis. Dysregulation of MARCH family ligases has been implicated in cancer, metabolic diseases, immune disorders, and primary ciliary dyskinesia. Although the biological context of MARCHF10's direct therapeutic targeting remains under investigation, E3 ubiquitin ligases are emerging as important drug targets because of their key regulatory roles in health and disease. No specific therapeutic drugs or biomarkers have yet been established for MARCHF10, but safety concerns for this family include risks of immune perturbation and off-target protein degradation due to broad substrate specificity.

Other names
Membrane-associated ring-CH-type finger 10MARCH10RNF190MARCH-XFLJ35757Membrane-associated RING finger protein 10Membrane-associated RING-CH protein XRing finger protein 190RING-type E3 ubiquitin transferase MARCHF10Testis secretory sperm-binding protein Li 228nEC 2.3.2.27
02

Mechanism of action

Ubiquitination of substrate proteins, Targeted proteasomal degradation, Posttranslational modification of membrane or signaling proteins

03

Biological functions

UbiquitinationRegulation of protein degradationImmune responseRegulation of protein traffickingRegulation of membrane protein stability
04

Disease associations

CancerMetabolic diseaseImmune dysregulationCiliary dyskinesia (specifically associated with primary ciliary dyskinesia 13)
05

Safety considerations

Potential off-target immune modulationrisk of unintended protein degradationlimited target validation as a therapeutic

Beyond the preview

Go deeper on Membrane-associated ring-CH-type finger protein 10 (MARCHF10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane-associated ring-CH-type finger protein 10 (MARCHF10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call